Cite

HARVARD Citation

    Flinn, I. et al. (n.d.). A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. American journal of hematology. 91 (9), pp. 900-906. [Online]. 
  
Back to record